| Literature DB >> 18627603 |
Nina Wedell1, Tom Tregenza, Leigh W Simmons.
Abstract
BACKGROUND: Because of the potential benefits to individuals of saving investment for future mating opportunities, there is conflict between mates over most aspects of reproduction. Males of many species transfer compounds in the ejaculate that manipulate female reproductive physiology to increase male reproductive success. These seminal compounds are often associated with direct and/or indirect costs to females. In contrast, in some species ejaculates also contain nutrients used by females for somatic maintenance and increased reproductive output. In general, the extent to which male seminal components are detrimental or beneficial to females is poorly understood, and interactions between seminal compounds with different effects have been almost completely neglected. Here we examine the impact of male receptivity-suppressing factors and nutrient donations on female longevity and lifetime reproductive output in the bushcricket Requena verticalis.Entities:
Mesh:
Year: 2008 PMID: 18627603 PMCID: PMC2491630 DOI: 10.1186/1471-2148-8-204
Source DB: PubMed Journal: BMC Evol Biol ISSN: 1471-2148 Impact factor: 3.260
Figure 1Female longevity in relation to spermatophylax consumption and number of ejaculates received. Females that receive three ejaculates (blue line) die sooner than females receiving only one ejaculate (green line). Spermatophylax consumption does not affect female lifespan (red line).
The effect of mating treatment on female reproduction
| Mating treatment | |||||
|---|---|---|---|---|---|
| Variable | 1 Ejaculate | 3 Ejaculates | Spermatophylax | ||
| Lifetime fecundity | 0.167 | 41.9 ± 9.8 | 42.3 ± 7.4 | 47.4 ± 8.1 | >0.8 |
| Mean egg weight | 1.089 | 2.29 ± 0.06 | 2.15 ± 0.05 | 2.18 ± 0.06 | >0.3 |
| Mass of eggs laid | 0.214 | 92.4 ± 19.1 | 89.2 ± 15.8 | 103.5 ± 15.8 | >0.8 |
| Oviposition rate 0–5 days | 1.009 | 3.04 ± 1.38 | 1.06 ± 0.61 | 1.34 ± 0.76 | >0.3 |
| Oviposition rate 6–10 days | 0.328 | 1.05 ± 0.53 | 1.39 ± 0.44 | 1.59 ± 0.49 | >0.7 |
| Oviposition rate 11–15 days | 1.253 | 0.78 ± 0.50 | 1.66 ± 0.52 | 1.80 ± 0.41 | >0.2 |
| Oviposition rate ≥ 16 days | 1.833 | 0.24 ± 0.04 | 0.55 ± 0.20 | 0.33 ± 0.05 | >0.1 |
The effect of mating treatment on female lifetime fecundity, mean egg weight (mg), mass of eggs laid (mg), and oviposition rate (eggs per day) in either of the four egg laying periods, together with means ± SE for each variable per treatment.
Figure 2Egglaying rate in relation to mating treatment. There is no difference in female egg-laying rate with respect to spermatophylax consumption or number of ejaculates received in either of the 4 egg-laying periods, and no influence of female size (p > 0.14 – > 0.99).